Sinocelltech Ltd.

This study tests a new drug called SCT520FF for people with wet age-related macular degeneration (nAMD), a leading cause of vision loss. The goal is to see if the drug is safe and can help control the disease by improving vision and reducing retinal swelling. About 82 adults aged…

This study tests a new medicine called SCTB14 against the standard drug pembrolizumab as the first treatment for people with advanced non-small cell lung cancer that has not spread to the brain. About 246 adults with a specific tumor marker (TPS ≥10%) will receive either SCTB14 o…

This study tests whether adding an experimental drug (SCTC21C) to standard chemotherapy helps people newly diagnosed with AL amyloidosis, a rare disease where abnormal proteins build up in organs. About 90 adults will be randomly assigned to get the new combo or chemo alone. The …

This study tests an experimental drug, SCT650C, in 60 adults with moderate to severe hidradenitis suppurativa (HS), a painful skin condition causing abscesses and scarring. Participants receive either the drug or a placebo to see if it reduces skin bumps and inflammation by at le…